Holen Sie sich die Stockscreener-App
6.00
6.40%
-0.41
Vorhandelsmarkt:
6.06
0.06
+1.00%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NVAX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$6.41
Offen:
$6.41
24-Stunden-Volumen:
5.38M
Relative Volume:
1.32
Marktkapitalisierung:
$965.07M
Einnahmen:
$847.25M
Nettoeinkommen (Verlust:
$-284.86M
KGV:
-2.6201
EPS:
-2.29
Netto-Cashflow:
$-112.35M
1W Leistung:
-20.63%
1M Leistung:
-27.97%
6M Leistung:
-51.30%
1J Leistung:
+29.03%
1-Tages-Spanne:
$5.995
$6.4281
1-Wochen-Bereich:
$5.995
$7.565
52-Wochen-Spanne:
$3.81
$23.86
Novavax Inc Stock (NVAX) Company Profile
Firmenname
Novavax Inc
Sektor
Branche
Telefon
240-268-2000
Adresse
700 QUINCE ORCHARD ROAD, GAITHERSBURG, MD
Vergleichen Sie NVAX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NVAX
Novavax Inc
|
6.00 | 965.07M | 847.25M | -284.86M | -112.35M | -2.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.74 | 124.48B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
617.00 | 67.45B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
567.09 | 34.59B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
255.76 | 33.10B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
271.04 | 29.15B | 3.81B | -644.79M | -669.77M | -6.24 |
Novavax Inc Stock (NVAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-28 | Eingeleitet | BTIG Research | Buy |
| 2024-07-30 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-05-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-05-10 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-08-09 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2023-04-20 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-03-01 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2023-01-09 | Bestätigt | B. Riley Securities | Buy |
| 2022-12-30 | Bestätigt | H.C. Wainwright | Buy |
| 2022-12-02 | Eingeleitet | Jefferies | Hold |
| 2022-09-22 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-05-20 | Eingeleitet | BofA Securities | Underperform |
| 2022-02-23 | Bestätigt | B. Riley Securities | Buy |
| 2022-02-22 | Fortgesetzt | Jefferies | Buy |
| 2022-01-21 | Eingeleitet | Cowen | Outperform |
| 2021-05-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-12-14 | Eingeleitet | Jefferies | Buy |
| 2020-08-06 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-08-05 | Herabstufung | Ladenburg Thalmann | Neutral → Sell |
| 2020-07-16 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-08 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-29 | Bestätigt | B. Riley FBR | Buy |
| 2020-06-29 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-05 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2020-05-28 | Bestätigt | B. Riley FBR | Buy |
| 2020-05-12 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-30 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-27 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-08-14 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-28 | Herabstufung | Piper Jaffray | Overweight → Underweight |
| 2018-12-18 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2018-12-11 | Eingeleitet | Oppenheimer | Outperform |
| 2018-11-26 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-09-21 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2018-03-29 | Hochstufung | Seaport Global Securities | Neutral → Buy |
Alle ansehen
Novavax Inc Aktie (NVAX) Neueste Nachrichten
Moderna, Novavax Stocks Fall After Top FDA Vaccine Official Forced Out - WSJ
Novavax Inc. stock underperforms Monday when compared to competitors - MarketWatch
Top vaccine official’s ouster sends biotech stocks tumbling - The Boston Globe
Vaccine stocks tumble: Moderna, Novavax, Pfizer fall after top FDA official resigns over RFK Jr. anti-vax views - Fast Company
Moderna, Novavax, Other Vaccine Makers Retreat Following Resignation of FDA's Vaccines Chief - MarketScreener
Moderna and Novavax shares plunge after key FDA official steps down, citing discord with RFK Jr. who he says ‘wishes subservient confirmation of his misinformation and lies’ - Yahoo Finance
Moderna and Novavax shares plunge after key FDA official steps down, citing discord with RFK Jr. who he says 'wishes subservient confirmation of his misinformation and lies' - Fortune
Moderna, Novavax Drop After FDA’s Top Vaccine Official Exits - Bloomberg
Biopharma, Biotech stocks tumble on FDA shakeup - Investing.com India
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Novavax seeks authorization of updated COVID shot in Europe - MSN
Novavax, Inc. (NVAX): Among Top High-Risk, High-Reward Growth Stocks To Buy Now - Yahoo Finance
Novavax Inc. stock underperforms Friday when compared to competitors - MarketWatch
Why Novavax (NVAX) Dipped More Than Broader Market Today - Yahoo Finance
Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Moderna, Novavax Shares Are Sliding Wednesday: What's Going On?Moderna (NASDAQ:MRNA) - Benzinga
Moderna, Novavax, and Pfizer shares fall amid U.S. vaccine fund cuts - Investing.com Australia
Where are the Opportunities in (NVAX) - Stock Traders Daily
Novavax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
The industry heavyweight behind Novavax’s push to bounce back - PharmaVoice
Novavax Inc. stock rises Monday, still underperforms market - MarketWatch
Ebola Vaccine Market Generated Opportunities, Future Scope - openPR
Novavax (NVAX) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know - Yahoo Finance
(NVAX) Technical Pivots with Risk Controls - Stock Traders Daily
2 Beaten-Down Stocks Near Their 52-Week Lows That Aren't Worth Buying - The Motley Fool
Canada cancels Novavax Covid vaccine purchase - New Vision
Canada cancels purchase of Covid-19 vaccine from Novavax - БГНЕС
Some Novavax, Inc. (NASDAQ:NVAX) Analysts Just Made A Major Cut To Next Year's Estimates - Simply Wall St
Head to Head Analysis: TScan Therapeutics (NASDAQ:TCRX) versus Novavax (NASDAQ:NVAX) - Defense World
Novavax Announces Board Changes and Strategic Shift - TipRanks
Novavax appoints new chair as James Young retires By Investing.com - Investing.com Australia
Need To Know: Analysts Just Made A Substantial Cut To Their Novavax, Inc. (NASDAQ:NVAX) Estimates - Yahoo Finance
Federal government cancels deal with US company to make COVID-19 vaccine in Montreal - Montreal Gazette
Novavax faces contract termination with Canadian government By Investing.com - Investing.com South Africa
Novavax falls as Canada terminates COVID-19 vaccine purchase deal - TradingView
Canada Cancels Novavax Covid Vaccine Purchase - Barron's
Novavax Faces Contract Termination with Canadian Government - TipRanks
Novavax faces termination of Covid-19 vaccine purchase deal with Canada due to missed regulatory approval deadlines, SEC filing shows - Marketscreener.com
Novavax: retirement of the Chairman of the Board of Directors -March 11, 2025 at 09:55 am EDT - Marketscreener.com
Novavax Lands Wall Street 'Buy' Rating After Q4 Results, Retail Bulls Eye More Upside On Sanofi Partnership - MSN
Novavax faces contract termination with Canadian government - Investing.com India
Novavax Chair James Young Retires; Margaret McGlynn Named Successor -March 11, 2025 at 09:02 am EDT - Marketscreener.com
Novavax appoints new chair as James Young retires - Investing.com India
Finanzdaten der Novavax Inc-Aktie (NVAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.89%
0.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):